FOLFIRI regimen as second-line treatment of metastatic gastric cancer: a retrospective analysis of efficacy, safety and prognostic factors. (2015). European Journal of Oncology and Environmental Health, 20(1), 32-40. https://mattioli1885journals.com/index.php/EJOEH/article/view/4168